The World Bank.
The control of human onchocerciasis (river blindness) is one of the most successful global partnerships ever supported by the World Bank. Mectizan mass treatments have greatly contributed to this success and have shaped the strategies of the programmes in which the World Bank has been involved - the Onchocerciasis Control Programme (OCP), which covered onchocerciasis control in West Africa until 2002, and the African Programme for Onchocerciasis Control (APOC), which is currently working in 30 countries, to protect millions of people from onchocerciasis. Through the strategy of community-directed treatment with ivermectin (CDTI), onchocerciasis control in Africa was transformed from a technologically-driven and vertical health initiative to a community-directed process of treatment and empowerment. Together, CDTI and the donation of Mectizan also reduced costs, producing one of the most effective and affordable disease-control schemes ever seen, and the CDTI strategy is now being applied to other disease-control initiatives. The onchocerciasis programmes have also been exemplary in shaping partnerships with communities, countries, the World Health Organization, governments, non-governmental development organizations, and the private sector. The Bank's involvement in onchocerciasis control has helped mobilize funds, giving confidence to other donors. More than U. S.$800 million was raised for both the OCP and APOC (excluding the initial costs of Mectizan). With these funds and the commitment of the partners involved, high coverages have been achieved in the Mectizan distributions. The Bank is confident that, during the years to come, the partners will continue their success, and that the APOC will achieve its goals by the target date for its closure, in 2015.
Bangoura
O
O
Onchocerciasis Coordination Unit, World Bank Africa Region, Room J9-093, 1818 H Street, NW, Washington, DC 20433, USA. obangoura@worldbank.org
D000349:Africa / Q000453:epidemiology; D000818:Animals; D003695:Delivery of Health Care / Q000191:economics; D003906:Developing Countries; D005369:Filaricides / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D007559:Ivermectin / Q000191:economics / Q000627:therapeutic use*; D009855:Onchocerciasis / Q000188:drug therapy / Q000517:prevention & control*; D015827:Onchocerciasis, Ocular / Q000517:prevention & control; D014480:United Nations / Q000191:economics
D005369:Filaricides; D007559:Ivermectin